TheraSonic aims to revolutionize the treatment of neurological diseases, particularly brain cancers.
TheraSonic has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
TheraSonic's investors include Institut Gustave Roussy, M2care.
TheraSonic is headquartered in Paris, France.
TheraSonic aims to revolutionize the treatment of neurological diseases, particularly brain cancers.
TheraSonic is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TheraSonic — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/therasonic. Accessed September 12, 2026.
VCBacked. (2024). TheraSonic — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/therasonic
{{cite web |title=TheraSonic — Funding & Investors |url=https://www.vcbacked.co/company/therasonic |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated